Liaison Q.S.E.T. Device Plus

Labelling and packaging

Date

2024-12-04

Country

Canada

Classification

Type II

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2024-12-05
2. CA
   Drugs & medicalType II

   Hank Cervical Dilator

   Labelling and packaging

   Health CanadaOfficial notice →
3. 2024-12-04
4. CA
   Drugs & medicalType I

   TEVA-Betahistine Tablets: Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-betahistine.

   Product safety

   Health CanadaOfficial notice →
5. CA
   Drugs & medicalType II

   Access hsTnI

   Performance

   Health CanadaOfficial notice →
6. CA
   Drugs & medicalType II

   Mic* Gastric-Jejunal Feeding Tube With Enfit Connectors (Endoscopic/Radiologic Placement Kit)

   Sterility

   Health CanadaOfficial notice →
7. 2024-12-02
8. CA
   Drugs & medicalType I

   ACURATE neo2 and ACURATE Prime

   Performance

   Health CanadaOfficial notice →
9. 2024-11-29
10. CA
    Drugs & medicalType II

    Florabile: The total combined yeasts and molds count may be out of specification for the affected lots.

    Product quality

    Health CanadaOfficial notice →